Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
NCT07074418
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Diseases
Interventions
DRUG:
Empagliflozin 10 MG then Placebo
DRUG:
Placebo then Empagliflozin 10 MG
Sponsor
Centre Hospitalier Universitaire de Nice
Collaborators
[object Object]